Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Exchange Rate Effect (2020 - 2025)

Mirum Pharmaceuticals (MIRM) has 6 years of Exchange Rate Effect data on record, last reported at -$408000.0 in Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 70.41% year-over-year to -$408000.0; the TTM value through Dec 2025 reached $3.2 million, up 348.42%, while the annual FY2025 figure was $3.2 million, 348.42% up from the prior year.
  • Exchange Rate Effect reached -$408000.0 in Q4 2025 per MIRM's latest filing, down from $349000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $2.2 million in Q2 2025 and bottomed at -$1.4 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $94894.7, with a median of $3000.0 recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: crashed 1733.33% in 2022, then soared 6366.67% in 2023.
  • A 5-year view of Exchange Rate Effect shows it stood at $5000.0 in 2021, then surged by 1600.0% to $85000.0 in 2022, then grew by 27.06% to $108000.0 in 2023, then plummeted by 1376.85% to -$1.4 million in 2024, then surged by 70.41% to -$408000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were -$408000.0 in Q4 2025, $349000.0 in Q3 2025, and $2.2 million in Q2 2025.